A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province

Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury

NCT05411705 ·Status: RECRUITING ·Phase: PHASE4

The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery

NCT06507436 ·Status: RECRUITING ·Phase: PHASE3

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

NCT05394285 ·Status: COMPLETED ·Phase: PHASE2

Romiplostim N01 for Chemotherapy-induced Thrombocytopenia

NCT07063225 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy

NCT05442632 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP

NCT06838949 ·Status: RECRUITING ·Phase: PHASE2

Eltrombopag for Chemotherapy-induced Thrombocytopenia

NCT04600960 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia

NCT07286032 ·Status: RECRUITING ·Phase: PHASE3

Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia

NCT06562738 ·Status: RECRUITING ·Phase: PHASE4

Avatrombopag for Chemotherapy-induced Thrombocytopenia

NCT05218226 ·Status: RECRUITING ·Phase: PHASE2

Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma

NCT05969158 ·Status: UNKNOWN ·Phase: PHASE2

An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA

NCT05333861 ·Status: NOT_YET_RECRUITING

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

NCT07243418 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

NCT05685420 ·Status: UNKNOWN ·Phase: PHASE3

A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia

NCT06376435 ·Status: NOT_YET_RECRUITING

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

NCT06287567 ·Status: COMPLETED ·Phase: PHASE2

Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors

NCT07128576 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

NCT07334093 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

NCT05143892 ·Status: UNKNOWN ·Phase: PHASE2

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

NCT05688306 ·Status: COMPLETED

Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia

NCT03825744 ·Status: COMPLETED ·Phase: PHASE3

Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.

NCT05392647 ·Status: UNKNOWN ·Phase: PHASE2

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

NCT05088642 ·Status: COMPLETED ·Phase: PHASE1

Herombopag + rhTPO in Severe Immune Thrombocytopenia

NCT05328804 ·Status: UNKNOWN ·Phase: PHASE3

Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation

NCT05727917 ·Status: UNKNOWN ·Phase: NA